R. Scott Areglado is the Chief Financial Officer (CFO) at MindWalk. Scott has more than 30 years of experience in finance and accounting with over 15 years experience in healthcare companies. From 2021 to 2023, Scott served as the CFO at BrainsWay, a global medical device leader in interventional psychiatry. Prior to BrainsWay, Scott served as the CFO at iCAD Inc., a medical technology company specializing in AI-driven cancer detection and therapy solutions. Prior to his appointment as CFO, he served as iCAD’s Vice President and Corporate Controller. From 2005 to 2010, Scottserved as Vice President and Controller at AMICAS, Inc., a Nasdaq-listed image and information management solutions company serving the healthcare industry, where he led financial statement preparation and accounting operations for the company leading to the successful acquisition by Merge Healthcare.
Scott received an MBA from the Franklin W. Olin Graduate School of Business at Babson College (Wellesley, Massachusetts) and a BBA degree in Accounting from the University of Massachusetts, Amherst.